• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NSB

NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD - News & Media

9.09% ! 18.0¢
Market Cap $59.86M  !

NeuroScientific Biopharmaceuticals Limited is an Australia-based company, which is... NeuroScientific Biopharmaceuticals Limited is an Australia-based company, which is engaged in developing peptide-based pharmaceutical drugs that target a number of neurodegenerative conditions with high unmet medical demand. The Company's product portfolio includes EmtinB, a therapeutic peptide initially targeting glaucoma, as well as other Emtin peptides (EmtinAc, EmtinAn and EmtinBn). EmtinB is a peptide-based compound that binds to surface-based cell receptors from the LDLR family, activating intracellular signalling pathways that stimulate neuroprotection, neuroregeneration and modulate neuroinflammation. EmtinB is modelled on a specific active domain of the complex human protein called Metallothionein-IIA, which is produced as part of the human body's innate immune response to cell injury. Its StemSmart is a global patented technology engaged in manufacturing cell products. The use of its proprietary StemSmart technology in a special access program for fistulising Crohn’s disease.More

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
18.0¢
Change
0.015(9.09%)
Mkt cap ! $59.86M
Open High Low Value Volume
17.5¢ 18.0¢ 17.0¢ $89.52K 510.3K

Buyers (Bids)

No. Vol. Price($)
1 50000 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 69933 3
View Market Depth
Last trade - 16.10pm 17/09/2025 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.